Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 19:51:13 +0200Wed, 10 Apr 2024 08:48:00 +0200Human medicines European public assessment report (EPAR): Aerinaze, desloratadine,pseudoephedrine, Date of authorisation: 30/07/2007, Revision: 23, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/aerinazeHuman medicines European public assessment report (EPAR): Aerinaze, desloratadine,pseudoephedrine, Date of authorisation: 30/07/2007, Revision: 23, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/aerinazeWed, 10 Apr 2024 08:48:00 +0200Human medicineReferral: Pseudoephedrine-containing medicinal products, pseudoephedrine Article 31 referrals European Commission final decision, 25/01/2024, 27/03/2024, 04/04/2024https://www.ema.europa.eu/en/medicines/human/referrals/pseudoephedrine-containing-medicinal-productsReferral: Pseudoephedrine-containing medicinal products, pseudoephedrine Article 31 referrals European Commission final decision, 25/01/2024, 27/03/2024, 04/04/2024https://www.ema.europa.eu/en/medicines/human/referrals/pseudoephedrine-containing-medicinal-productsThu, 04 Apr 2024 15:49:00 +0200Human medicineAerinaze-H-C-PSUSA-963-201607 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisationshttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500228484_en.pdfAerinaze-H-C-PSUSA-963-201607 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisationshttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500228484_en.pdfMon, 29 May 2017 16:20:00 +0200Human medicine